The latest news in the prevention and management of diabetic foot disease, the podiatric programme at IKEM
Authors:
A. Jirkovská
Authors place of work:
Institut klinické a experimentální medicíny, Praha
; Přednostka: prof. MUDr. Terezie Pelikánová, DrSc.
; Centrum diabetologie
Published in the journal:
Prakt. Lék. 2011; 91(1): 21-26
Category:
40th Anniversary IKEM
Summary
The Podiatric programme at IKEM is based on hospital multidisciplinary foot team cooperation, mainly among diabetologists, surgeons and intervention radiologists and is coordinated by the IKEM Diabetes Centre. Prevention and management of diabetic foot disease remain, despite the progress to date, problematic. A survey of the number of patients with diabetic foot disease and amputation in the Czech Republic during recent years show a permanent increase of the prevalence of the disease.
Appropriate management of this severe late diabetic complication requires strict implementation of the International Diabetic Foot Consensus and the guidelines of The Czech Diabetes Society and it is possible only with a multidisciplinary team approach in diabetic foot clinics and the constant education of specialists, especially
- diabetologists,
- surgeons,
- interventional radiologists,
- diabetic foot assistants, and
- rosthetics specialists
The Diabetes Centre and one of clinics, diabetic foot clinic, at IKEM are very active both with patients with diabetic foot management and health professional education and research: e.g. a survey of number of patient’s visits at the foot clinic at IKEM between 2000 and 2009 indicated an increase from 3 800 to 7 950 visits per year and the certificated diabetic foot care assistant course was started in 2009.
Great experience with management of Charcot osteoarthropathy and new current research methods such as
- biological debridement,
- vacuum assisted closure, and
- stem cells therapy
were proven successful.
Thanks to co-operation with competent specialists, percutaneous transluminal angioplasty of the below-knee arteries and diabetic foot surgery specialized technique achieved considerable progress.
Key words:
diabetic foot disease, podiatric medicine, diabetes mellitus.
Zdroje
1. American Podiatric Medical Association. Podiatric medicine: a guide for hospitals. ADA, Bethesda: ADA 1995.
2. Apelqvist, J. The foot in perspective. Diabetes. Metab. Res. Rev. 2008, 24, Suppl 1, p. 110-115.
3. Apelqvist, J., Bakker, K., van Houtum, W.H., Schaper, N.C. International Working Group on the Diabetic Foot (IWGDF) Editorial Board. Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) Prepared by the International Working Group on the Diabetic Foot. Diabetes Metab. Res. Rev. 2008, 24, Suppl 1, p. 181-187.
4. Armstrong, D.G., Salas, P., Short, B. et al. Maggot therapy in “lower-extremity hospice” wound care: fewer amputations and more antibiotic-free days. J. Am. Podiatr. Med. Assoc. 2005, 95, p. 254-257.
5. Bem, R., Jirkovská, A., Fejfarová, V. et al. Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial. Diabetes Care 2006, 29, p. 1392-1394.
6. Bem, R., Jirkovská, A., Dubsky, M., Fejfarová, V. et al. Role of quantitative bone scanning in the assessment of bone turnover in patients with Charcot foot. Diabetes Care 2010, 33, p.348-349.
7. Bevilacqua, N.J., Rogers, L.C., Armstrong, D.G. Diabetic foot surgery: classifying patients to predict complications. Diabetes Metab. Res. Rev. 2008, 24, Suppl 1, p. 81-83.
8. Boulton, A.J., Armstrong, D.G., Albert,.S.F. et al., American Diabetes Association. American Association of Clinical Endocrinologists. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 2008, 31, p.1679-1685.
9. Dubský, M., Jirkovská, A., Bém, R., Fejfarová, V. a kol. Možnosti buněčné terapie ischemické choroby dolních končetin u syndromu diabetické nohy. DMEV 2009, 12, s. 128-132
10. Edmonds, M.E., Blundell, M.P., Morris, M.E. et al. Improved survival of the diabetic foot: the role of special foot clinic. Q. J. Med. 1986, 60, p. 763-771.
11. Expert Working Group.Vacuum assisted closure: recommendations for use. A consensus document. Int. Wound J. 2008, 5, Suppl 4, p. 11-19.
12. Fejfarová, V., Jirkovská, A., Petkov, V. et al. Comparison of microbial findings and resistance to antibiotics between transplant patients, patients on hemodialysis, and other patients with the diabetic foot. J. Diabetes Complications 2004, 18, p. 108-112.
13. Hinchliffe, R.J., Valk, G.D., Apelqvist, J., Armstrong, D.G. et al. A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab. Res. Rev. 2008, 24, Suppl 1, p.119-144.
14. Chantelau, E. Das Syndrom des diabetischen Fusses. Dtsch. Med. Wschr. 1989.
15. Janoušek, L., Tošenovský, P., Zálešák, B. Chirurgická revaskularizace diabetické nohy. In Jirkovská, A. a kol. Syndrom diabetické nohy.Praha: Maxdorf , 2006, s. 148-161.
16. Jirkovská, A., Boucek, P., Wosková, V. et al. Identification of patients at risk for diabetic foot: a comparison of standardized noninvasive testing with routine practice at community diabetes clinics. J. Diabetes Complications 2001, 15, p. 63-68.
17. Jirkovská, A., Kasalický, P., Boucek, P. et al. Calcaneal ultrasonometry in patients with Charcot osteoarthropathy and its relationship with densitometry in the lumbar spine and femoral neck and with markers of bone turnover. Diabet. Med. 2001, 18, p. 495-500.
18. Jirkovská, A., Boucek, P., Wu, S. et al. Power spectral analysis of heart rate variability in patients with Charcot’s neuroarthropathy. J. Am. Podiatr. Med. Assoc. 2006, 96, p. 1-8.
19. Jirkovská A. Hojení kožních afekcí u syndromu diabetické nohy při hospitalizaci. Vnitr. Lek.2006, 52, s. 459-464.
20. Jirkovská, A. a kol. Syndrom diabetické nohy. Praha: Maxdorf, 2006.
21. Jirkovská, A., Bém, R., Novotný, K. et al. Larvální léčba ran se zaměřením na syndrom diabetické nohy. Prakt. Lék., 2007, 87, s. 559-563.
22. Jude, E.B., Selby, P.L., Burgess et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia 2001, 44, p. 2032-2037.
23. Jude, E.B., Eleftheriadou, I., Tentolouris, N. Peripheral arterial disease in diabetes - a review. Diabet. Med., 2010, 27, p. 4-14.
24. Larsson, J., Apelqvist, J., Agardh, C.D., Stenström, A. Decreasing incidence of major amputation in diabetic patients: a consequence of multidisciplinary foot care team approach? Diab. Med. 1995, 12, p.770-776.
25. Lavery, L.A., Armstrong, D.G. Temperature monitoring to assess, predict, and prevent diabetic foot complications. Curr. Diab. Rep. 2007, 7, p. 416-419.
26. Lawall, H., Bramlage, P., Amann, B. Stem cell and progenitor cell therapy in peripheral artery disease, Thromb. Haemost. 2010, 103, p. 696–709.
27. Matricali, G., Dereymaeker, G., Muls, E. et al. Economic aspects of diabetic foot care in multidisciplinary setting:a review. Diabetes Metab. Res. rev. 2007, 23, p. 339-347.
28. Mezinárodní pracovní skupina pro syndrom diabetické nohy: Syndrom diabetické nohy. Mezinárodní konsenzus. České vydání Praha: Galén, 2000.
29. Molines, L., Darmon, P., Raccah, D. Charcot’s foot: newest findings on its pathophysiology, diagnosis and treatment. Diabetes Metab. 2010, 36, p. 251-255.
30. Peregrin, J.H., Koznar, B., Kovác J. et al. PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome. Cardiovasc. Intervent. Radiol., 2010, 33, p. 720-725.
31. Prompers, L., Huijberts, M., Apelqvist J. et al. Optimal organization of health care in diabetic foot disease: introduction to the Eurodiale study. Int. J. Low. Extrem Wounds, 2007, 6, p. 11-17.
32. Prompers, L., Huijberts, M., Apelqvist J. et al. Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale Study, a prospective cohort study. Diabet. Med. 2008, 25, p. 700-707.
33. Sixta, B., Varga, M., Jirkovská, A. Porovnání výsledků resekcí MTP kloubů a ulcerektomií s ostatními chirurgickými výkony na diabetické noze. Bulletin HPB, 2007, 15, s. 89-92.
34. Valk, G.D., Kriegsman, D.M., Assendelft, W.J. Patient education for preventing diabetic foot ulceration. Endocrinol. Metab. Clin. North. Am. 2002, 3, p. 633-658.
Štítky
General practitioner for children and adolescents General practitioner for adultsČlánok vyšiel v časopise
General Practitioner
2011 Číslo 1
- Memantine Eases Daily Life for Patients and Caregivers
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole vs. Tramadol in Postoperative Analgesia
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
Najčítanejšie v tomto čísle
- The evaluation of patients for the kidney transplantation waiting list
- Oral antidiabetic drugs
- Diabetes center and diabetology program in IKEM
- The latest news in the prevention and management of diabetic foot disease, the podiatric programme at IKEM